STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Oculis Publishes Notifications of Transactions by Person Discharging Managerial Responsibilities

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags

Oculis has disclosed multiple notifications regarding transactions executed by a Person Discharging Managerial Responsibilities (PDMR) under a pre-planned 10b5-1 trading plan. The sales transactions were conducted by R. Sherif over five consecutive days from March 14-20, 2025, in compliance with Rule 10b5-1(c)(1) of the Securities Exchange Act of 1934.

Loading...
Loading translation...

Positive

  • Transactions executed through proper regulatory channels via 10b5-1 trading plan

Negative

  • Multiple insider stock sales by PDMR could signal reduced confidence in company prospects

ZUG, Switzerland, March 20, 2025 (GLOBE NEWSWIRE) -- The attached notifications relate to trades entered into by a PDMR of the Company pursuant to a 10b5-1 trading plan, in accordance with Rule 10b5-1(c)(1) of the Securities Exchange Act of 1934, as amended.

Attachments


FAQ

What type of transactions did Oculis (OCS) report in March 2025?

Oculis reported multiple stock sales transactions by PDMR R. Sherif, executed under a 10b5-1 trading plan between March 14-20, 2025.

Who conducted the reported stock sales at Oculis (OCS)?

R. Sherif, a Person Discharging Managerial Responsibilities (PDMR) at Oculis, conducted the reported stock sales.

What is the regulatory framework governing these Oculis (OCS) transactions?

The transactions were executed under Rule 10b5-1(c)(1) of the Securities Exchange Act of 1934, which allows for pre-planned trading by company insiders.

When did the reported Oculis (OCS) PDMR transactions take place?

The transactions occurred over five consecutive days from March 14 through March 20, 2025.
Oculis Holding

NASDAQ:OCS

OCS Rankings

OCS Latest News

OCS Latest SEC Filings

OCS Stock Data

1.09B
48.60M
6.31%
31.25%
0.02%
Biotechnology
Healthcare
Link
Switzerland
Zug